NLVP
ACAD icon

New Leaf Venture Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

New Leaf Venture Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-177,230
Closed -$7.42M – 14
2015
Q2 		$7.42M Buy
177,230
+44,169
+33% +$1.71M 4.92% 7
2015
Q1 		$4.34M Buy
133,061
+64,300
+94% +$2.21M 2.94% 9
2014
Q4 		$2.18M Buy
+68,761
New +$1.95M 1.06% 10

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New Leaf Venture Partners's ACAD Position: Q3 2015 in Review

New Leaf Venture Partners sold out of Acadia Pharmaceuticals (ACAD) in Q3 2015, closing a stake of 177,230 shares — an estimated $7.42M sold.

New Leaf Venture Partners first reported a position in ACAD in Q4 2014 and held it in 3 quarters. The position peaked at $7.42M in Q2 2015. 188 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

  • New Leaf Venture Partners reported no remaining Acadia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • New Leaf Venture Partners sold 177,230 Acadia Pharmaceuticals shares in Q3 2015, an estimated $7.42M.
  • New Leaf Venture Partners first reported a position in Acadia Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • New Leaf Venture Partners's Acadia Pharmaceuticals position peaked at $7.42M in Q2 2015.
  • 188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on New Leaf Venture Partners's 13F filing for Q3 2015, filed 16 Nov 2015.